We believe Genmab is in solid financial health. At the end of 2024, Genmab held DKK 9.9 billion in cash and cash equivalents. After turning profitable in 2013, the company has steadily increased its ...
During a Case-Based Roundtable® event, Natalie Galanina, MD, reviewed how outcomes have changed in patients with primary ...
For Black Americans, the battle with Chronic Myeloid Leukemia is marked by unique survival challenges and treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback